PYRA-2
PYRA-2 is a CDC7 kinase inhibitor with potential for cancer research[1].
Product Specifications
UNSPSC
12352005
Target
CDK
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/pyra-2.html
Solubility
10 mM in DMSO
Smiles
O=C1N(S(=O)(C2=CC=C(C)C=C2)=O)N=C(C)/C1=N\NC3=CC=C(F)C=C3F
Molecular Formula
C17H14F2N4O3S
Molecular Weight
392.38
References & Citations
[1]Mookkan M, et al. A Structural and In Silico Investigation of Potential CDC7 Kinase Enzyme Inhibitors. ACS Omega. 2023 Nov 27;8 (49) :47187-47200.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
![1- (2-{[ (tert-Butoxy) carbonyl]amino}ethyl) -5- (methoxycarbonyl) -2-oxo-1,2-dihydropyridine-3-carboxylic acid](https://cdn.genprice.uk/genprice/uk/genprice2.webp)
MKD58850-01 50 mg
1- (2-{[ (tert-Butoxy) carbonyl]amino}ethyl) -5- (methoxycarbonyl) -2-oxo-1,2-dihydropyridine-3-carboxylic acid
Sign In for Pricing
View Details MKD58850-02 0.5 g
1- (2-{[ (tert-Butoxy) carbonyl]amino}ethyl) -5- (methoxycarbonyl) -2-oxo-1,2-dihydropyridine-3-carboxylic acid
Sign In for Pricing
View Details 
GTR15117853 1 Vial
Lentiviral human FBXO34 shRNA (UAS) - Lentiviral human FBXO34 shRNA (UAS, RFP) plasmid
Sign In for Pricing
View Details 